Herein, we investigated the prophylactic and therapeutic effect of two IL-2 complexes (JES6/IL-2 and S4B6/IL-2) on SLE-like symptoms resulting from chronic GvHD. This evidence concerns the gene IL2 and chronic graft versus host disease.